The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has recommended granting approval to Novo Nordisk India for its proposed update to ...
A new analysis suggests that people with type 2 diabetes who use GLP-1 medications like Ozempic, Trulicity or Victoza may be ...
Find Ozempic Complications Latest News, Videos & Pictures on Ozempic Complications and see latest updates, news, information from NDTV.COM. Explore more on Ozempic Complications.
Elevating Aesthetic Dermatology in Rockville with Innovative Med Spa Services Under CEO Janine Shore’ Rockville, United States – December 11, 2025 / Shore Dermatology / Shore Dermatology, a ...
Vikrant Shrotriya, Novo Nordisk India MD responds to questions on future pricing, generics competition post patent expiry in March, Indian-specific pricing, demand in India & quality. “India is not a ...
Newspoint on MSN
Weight loss medicines: Weight loss medicines in 2026, which medicines are available in India?
Weight loss medications like Ozempic are bringing new hope for weight loss in India on December 12, 2025. Learn about Ozempic ...
Ozempic (injectable semaglutide), one of the most evidence-backed advancements in diabetes care, was recently launched in ...
Eli Lilly's innovation and pipeline diversification support long-term growth, despite patent risks and competition. Read more ...
Recent clinical trials of Novo Nordisk’s blockbuster GLP-1 drug semaglutide for Alzheimer’s disease may have failed to show ...
But even as Ozempic enters India, there is a growing sense globally that Novo may have already lost the obesity drug war to Mounjaro, Eli Lilly’s blockbuster that has become India’s top-selling drug ...
A cardiologist's assertion that Ozempic is a \"cardiometabolic medicine\" rather than just a weight-loss trend has sparked ...
This article originally published at Pauline Potter-'My 600-lb Life' star and once Guinness-record holder-dies at 62, son ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results